Memorializing Governor Kathy Hochul to proclaim May 2026, as Cystic Fibrosis Awareness Month in the State of New York
Summary
This resolution memorializes Governor Kathy Hochul to proclaim May 2025 as Cystic Fibrosis Awareness Month in New York State. It is a ceremonial measure that recognizes cystic fibrosis as a serious genetic disease, describes its effects on the lungs and digestive system, and highlights the importance of early diagnosis, treatment, and ongoing research. The resolution also notes the number of people affected in New York and nationwide, the growing adult CF population, and the role of specialized treatment centers and innovative therapies.
The measure does not create or amend any substantive law, impose regulatory requirements, or appropriate funds. Instead, it serves as a formal legislative expression of support for awareness efforts and for individuals and families affected by cystic fibrosis. By transmitting the resolution to the Governor, the Legislature seeks to encourage public recognition of the disease and support broader educational and advocacy efforts during the designated month.
Impact
The resolution has no direct legal effect on state statutes, agency authority, or private rights. Its impact is symbolic and promotional: it encourages statewide awareness of cystic fibrosis, supports public-health education, and acknowledges the work of treatment centers and advocates. The affected parties are primarily people living with cystic fibrosis, their families, healthcare providers, researchers, and advocacy organizations, especially those in New York.
Sentiment
The overall sentiment is strongly supportive and noncontroversial. The resolution is framed as a compassionate public-health recognition measure, and the text emphasizes the seriousness of cystic fibrosis, the need for early detection, and the value of innovative treatment. Because it is an awareness-month proclamation rather than a policy change, there is no evidence of opposition in the available materials.
Contention
There is little to no apparent contention in the bill text or available context. The resolution focuses on awareness and recognition, and no committee debate, votes, or amendments are provided. If any issue could be inferred, it would be the broader public-health concern that awareness alone is insufficient without continued access to screening, treatment, and advanced therapies, but no specific disagreement is documented.